Status: current, Defined. Date: 31-Dec 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4497071000168118 | Piperacillin/Tazobactam 2 g/0.25 g (Kabi) (piperacillin 2 g + tazobactam 250 mg) powder for injection, 5 x 2.25 g vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4497081000168115 | Piperacillin/Tazobactam 2 g/0.25 g (Kabi) powder for injection, 5 x 2.25 g vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Piperacillin/Tazobactam 2 g/0.25 g (Kabi) powder for injection, 5 x 2.25 g vials | Is a | piperacillin 2 g + tazobactam 250 mg injection, 5 x 2.25 g vials | true | Inferred relationship | Some | ||
| Piperacillin/Tazobactam 2 g/0.25 g (Kabi) powder for injection, 5 x 2.25 g vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Piperacillin/Tazobactam 2 g/0.25 g (Kabi) powder for injection, 5 x 2.25 g vials | has TP | Piperacillin/Tazobactam 2 g/0.25 g (Kabi) | true | Inferred relationship | Some | ||
| Piperacillin/Tazobactam 2 g/0.25 g (Kabi) powder for injection, 5 x 2.25 g vials | has TPUU | Piperacillin/Tazobactam 2 g/0.25 g (Kabi) powder for injection, 2.25 g vial | true | Inferred relationship | Some | 2080642663 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Piperacillin/Tazobactam 2 g/0.25 g (Kabi) powder for injection, 5 x 2.25 g vials | Is a | True | Piperacillin/Tazobactam 2 g/0.25 g (Kabi) powder for injection, 5 x 2.25 g vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR